Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe (BIOFLEX-I EU)
BIOTRONIK - The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar-18 Stents (BIOFLEX-I Europe)
Sponsor: Biotronik AG
Listed as NCT01661231, this NA trial focuses on Peripheral Artery Disease and Peripheral Vascular Disease and remains ongoing. Sponsored by Biotronik AG, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Mar 2019 — Jan 2021 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Mar 2019 [monthly]
Active Not Recruiting NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Oct 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Biotronik AG
- Biotronik, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .